Tyra Biosciences, Inc.
TYRA
$36.22
$0.220.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.70% | -33.37% | -30.86% | -27.82% | -25.09% |
| Total Depreciation and Amortization | 5.20% | 16.98% | 27.94% | 36.36% | 45.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.02% | 66.74% | 78.21% | 53.85% | 37.78% |
| Change in Net Operating Assets | -123.32% | -174.61% | -185.83% | 310,600.00% | -111.46% |
| Cash from Operations | -36.36% | -42.99% | -37.58% | -17.46% | -39.16% |
| Capital Expenditure | 78.77% | 92.86% | 92.03% | 37.34% | 13.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 174.28% | 118.16% | 130.17% | 33.21% | 32.05% |
| Cash from Investing | 173.64% | 118.03% | 129.99% | 33.24% | 31.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.00% | -97.96% | -97.91% | -97.89% | 13,078.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | -48.52% | -- |
| Cash from Financing | -95.99% | -97.96% | -97.91% | -98.01% | 13,051.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -142.93% | 62.47% | 99.25% | -1,313.15% | 117.58% |